November 28th 2024
Researchers at the University of Colorado Anschutz Medical Campus found that characters with crossed or drifting eyes are more likely to play more minor roles in animated movies and be considered unintelligent or villainous. These depictions, the researchers say, can have harmful effects for children with strabismus by perpetuating stereotypes.
November 28th 2024
November 23rd 2024
November 14th 2024
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
EnVision Summit
February 14-17, 2025
Register Now!
Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments
March 16, 2025
Register Now!
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Coming home in the evening, I sometimes feel compelled to share with my daughter and spouse something I learned at work that day. This is always a mistake. Invariably my wisdom is greeted with a quick retort from my teenage daughter: "Dad, stop talking." My darling wife and love of my life is more generous; after expressing interest and asking a few questions, she tells me where I have gone wrong. Sometimes this results in an argument, as it did on this evening.
Read More
Book helps kids prepare for eye surgery
August 15th 2006As a pediatric ophthalmologist, Mark Silverberg, MD, relies on special tactics and tools to make his young patients feel at ease. Dr. Silverberg is pleased to have a new book to share with kids and their families that tells the story of eye surgery from a child's perspective, in simple terms with illustrative photographs.
Read More
Pediatric ocular allergy can be alleviated
August 15th 2006Chicago-High allergen counts this season combined with increased parental awareness about the potential functional impact of allergic conjunctivitis are leading to an increase in the number of pediatric patients being seen for control of ocular allergy.
Read More
Long-acting azithromycin safe, effective in treating bacterial conjunctivitis
July 15th 2006Fort Lauderdale, FL-An investigational longacting solution of 1.0% azithromycin (AzaSite, InSite Vision) is safe, well tolerated, and effective for the treatment of bacterial conjunctivitis in pediatric patients and adults, according to the results of pivotal phase III clinical trial involving placebo and active controls.
Read More
ECP at time of phaco effectively lowers IOP
July 15th 2006I have been using endoscopic cyclophotocoagulation (ECP) to treat patients with cataract and medically controlled glaucoma for 5 1/2 years and have found it to be a very useful addition to my armamentarium. The procedure is particularly attractive as an adjunct to small-incision cataract surgery. It takes only about 5 to 10 extra minutes to add ECP to phacoemulsification.
Read More
UCLA's Dr. Demer named to Leonard Apt endowed chair
June 15th 2006Los Angeles-Joseph L. Demer, MD, PhD, a noted authority on extraocular muscle movement, has been named the first holder of the Leonard Apt Endowed Chair in Pediatric Ophthalmology at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA).
Read More
Proposals given for ROP detection and treatment
June 15th 2006San Francisco-The American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and American Academy of Pediatrics released a series of recommendations on which to base effective detection and treatment of retinopathy of prematurity (ROP). The groups discuss improvements in the possible treatment of ROP and the importance of carefully timed retinal exams by an ophthalmologist for at-risk premature infants.
Read More
Essilor now offers Definity lenses nationwide
May 15th 2006Dallas-Essilor of America Inc. now offers Definityprogressive lenses through its network of laboratories and otherselect labs nationwide. Definity lenses feature Dual Add, apatented technology that maximizes available design space of thelens, minimizing peripheral distortion and providing a smoothertransition between all distances.
Read More
Pediatric vision screening worthy of advocacy
May 1st 2006Sacramento, CA-Obtaining reimbursement and resources forvision screening seems to be a thankless task with little return.However, there are strategies that can be used to give pediatricvision screening a fair share of the available health-care funds,according to James Bradford Ruben, MD.
Read More
Vision screening standardization recommended
April 15th 2006Portland, OR?Mass vision screening of school-age children was first recommended in 1983. At that time there was not a large population of children of preschool age, a situation that has changed markedly since then because today many more 3- and 4-year-olds are in a preschool setting. However, there is still no standardization in vision screening.
Read More
Screenings for amblyopia should be standardized
April 15th 2006Madison, WI - Uniform testing and reporting criteria are needed toidentify amblyogenic risk factors in children and prevent thedevelopment of amblyopia. Leslie W. France, CO, described theevidence base for the guidelines to detect amblyogenic riskfactors.
Read More
Corticosteroid provides potent, safe ocular allergy control
April 1st 2006Experience from clinical trials and daily clinical practice indicate that loteprednol etabonate 0.2% (Alrex, Bausch & Lomb) is a valuable therapeutic option for both short- and longer-term management of allergic conjunctivitis, according to ophthalmologists who have studied and used this novel anti-inflammatory corticosteroid agent.
Read More
Pretreat eye allergies for better surgical results
April 1st 2006Dorado, Puerto Rico?Patients with allergies should be identified and treated before undergoing ophthalmic surgery in order to improve healing for optimal visual outcomes, explained Francis S. Mah, MD, who spoke during the Current Concepts in Ophthalmology meeting in Dorado, Puerto Rico.
Read More
Pediatricians should take the lead in vision screening
March 1st 2006Chicago—Screening to detect preclinical vision loss in children is important and should ideally be done in the offices of pediatricians or family practitioners. In addition, it is now time to add objective testing to pediatric practices, according to Robert W. Arnold, MD, who spoke at the annual meeting of the American Academy of Ophthalmology.
Read More
Efficacy, once-daily convenience make drug good choice
January 15th 2006Portland, OR—The novel formulation of timolol maleate 0.5% ophthalmic solution containing potassium sorbate (Istalol, ISTA Pharmaceuticals) is a good option to consider for adjunctive therapy in patients whose IOP is not adequately controlled by a prostaglandin analogue alone, said John R. Samples, MD.
Read More
The complaint of double vision can cause confusion
January 15th 2006Chicago—Clinicians should use a systematic approach when confronted with the complaint of double vision. Knowing the possible symptoms and signs associated with diplopia can help with the diagnosis, explained Kimberly Cockerham, MD, FACS, at the neuro-ophthalmology subspecialty day meeting during the American Academy of Ophthalmology annual meeting.
Read More
High degree of suspicion needed for diagnosis of acute orbitopathies
January 1st 2006Chicago-"When is a lid laceration not just a lid laceration?" When it is occult penetrating orbito-cranial trauma, explained Roger E. Turbin, MD, assistant professor of ophthalmology and associate director of neuro-ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School.
Read More
Favorable outcomes persist with pediatric ICL
December 1st 2005Toulouse, France—With lengthening follow-up, the posterior chamber implantable collamer lens (ICL) (STAAR Surgical) continues to be associated with encouraging results in the management of refractive amblyopia in children who have not had a response to conventional therapy with contact lenses or spectacles, said Laurence C. Lesueur, MD.
Read More
Encapsulated trabeculectomy blebs resolve in study
December 1st 2005Houston—Filtering bleb encapsulation after trabeculectomy seems to respond well to tapering topical corticosteroids alone or in conjunction with IOP-lowering agents. Withdrawing steroids appeared beneficial for lowering the IOP compared with continuing the use of steroids to prevent inflammation, according to Sheila Bazzaz, MD.
Read More
NSAIDs help control inflammation, prevent CME
November 15th 2005With cataract and refractive procedures, ocular comfort and inflammation management are highly relevant to the patient's impression of a successful procedure. Add to that an expectation that an increase in visual acuity will follow closely on the heels of surgery, and the standards are set very high.
Read More
Dose moderation key in limiting toxicity of intracameral triamcinolone
October 17th 2005Intracameral triamcinolone acetonide (Kenalog, Bristol?Myers Squibb) used judiciously offers simple and safe anti-inflammatory treatment in cataract surgery patients, said James P. Gills, MD, at "Spotlight on Cataract Surgery in 2005" during the annual meeting of the American Academy of Ophthalmology.
Read More
Diplopia may be first sign of giant cell arteritis
October 17th 2005A number of pathologies can be confused with giant cell arteritis, Anthony Arnold, MD, explained Monday at the American Academy of Ophthalmology annual meeting. Patients with a painful ophthalmoplegia might have an isolated cranial neuropathy, a skull-based or cavernous sinus process such as a tumor, or an inflammatory or infiltrative process, an orbital process, a brainstem process, or a vasculitic process.
Read More
Causes of childhood blindness changing
October 16th 2005The patterns of childhood blindness and visual impairment are changing over time, according to Clare Gilbert, MD, MSc. Dr. Gilbert described the shifts in pediatric blindness patterns resulting from the ?nurture? factors Sunday at the American Academy of Ophthalmology annual meeting.
Read More